Primary open-angle glaucoma
Tóm tắt
Từ khóa
Tài liệu tham khảo
Quigley, 1996, Number of people with glaucoma worldwide, Br J Ophthalmol, 80, 389, 10.1136/bjo.80.5.389
Rahmani, 1996, The cause-specific prevalence of visual impairment in an urban population. The Baltimore Eye Survey, Ophthalmology, 103, 1721, 10.1016/S0161-6420(96)30435-1
Quigley, 1997, Models of open-angle glaucoma prevalence and incidence in the United States, Invest Ophthalmol Vis Sci, 38, 83
Javitt, 1993, Preparing for managed competition: utilization of ophthalmologic services varies by state, Arch Ophthalmol, 111, 1469, 10.1001/archopht.1993.01090110027013
Fechtner, 1994, Mechanisms of optic nerve damage in primary open angle glaucoma, Surv Ophthalmol, 39, 23, 10.1016/S0039-6257(05)80042-6
Weber, 2000, Experimental glaucoma and cell size, density, and number in the primate lateral geniculate nucleus, Invest Ophthalmol Vis Sci, 41, 1370
Yucel, 2000, Loss of neurons in magnocellular and parvocellular layers of the lateral geniculate nucleus in glaucoma, Arch Ophthalmol, 118, 378, 10.1001/archopht.118.3.378
Yucel, 2001, Atrophy of relay neurons in magno- and parvocellular layers in the lateral geniculate nucleus in experimental glaucoma, Invest Ophthalmol Vis Sci, 42, 3216
Yucel, 2003, Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma, Prog Retin Eye Res, 22, 465, 10.1016/S1350-9462(03)00026-0
Crawford, 2001, Experimental glaucoma in primates: changes in cytochrome oxidase blobs in VI cortex, Invest Ophthalmol Vis Sci, 42, 358
Sample, 2000, Visual function-specific perimetry for indirect comparison of different ganglion cell populations in glaucoma, Invest Ophthalmol Vis Sci, 41, 1783
Pena, 2001, Increased elastin expression in astrocytes of the lamina cribrosa in response to elevated intraocular pressure, Invest Ophthalmol Vis Sci, 42, 2303
Wang, 2002, Immunohistologic evidence for retinal glial cell changes in human glaucoma, Invest Ophthalmol Vis Sci, 43, 1088
Bellezza, 2003, Deformation of the lamina cribrosa and anterior scleral canal wall in early experimental glaucoma, Invest Ophthalmol Vis Sci, 44, 623, 10.1167/iovs.01-1282
Quigley, 2000, Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats, Invest Ophthalmol Vis Sci, 41, 3460
Weinreb, 1997, Optic nerve blood flow, 59
Lipton, 2003, Possible role for memantine in protecting retinal ganglion cells from glaucomatous damage, Surv Ophthalmol, 48, S38, 10.1016/S0039-6257(03)00008-0
Dreyer, 1996, Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma, Arch Ophthalmol, 114, 299, 10.1001/archopht.1996.01100130295012
Yoles, 1998, Elevation of intraocular glutamate levels in rats with partial lesion of the optic nerve, Arch Ophthalmol, 116, 906, 10.1001/archopht.116.7.906
Liu, 2001, Nitric oxide synthase-2 in human optic nerve head astrocytes induced by elevated pressure in vitro, Arch Ophthalmol, 119, 240
Yan, 2000, Matrix metalloproteinases and tumor necrosis factor alpha in glaucomatous optic nerve head, Arch Ophthalmol, 118, 666, 10.1001/archopht.118.5.666
Schwartz, 2003, Neurodegeneration and neuroprotection in glaucoma: development of a therapeutic neuroprotective vaccine—the Friedenwald lecture, Invest Ophthalmol Vis Sci, 44, 1407, 10.1167/iovs.02-0594
Tezel, 1999, Serum autoantibodies to optic nerve head glycosaminoglycans in patients with glaucoma, Arch Ophthalmol, 117, 917, 10.1001/archopht.117.7.917
John, 1999, Mouse genetics: a tool to help unlock the mechanisms of glaucoma, J Glaucoma, 8, 400, 10.1097/00061198-199912000-00011
Aihara, 2003, Ocular hypertension in mice with a targeted type I collagen mutation, Invest Ophthalmol Vis Sci, 44, 1581, 10.1167/iovs.02-0759
Danias, 2003, Quantitative analysis of retinal ganglion cell (RGC) loss in aging DBA/2NNia glaucomatous mice: comparison with RGC loss in aging C57/BL6 mice, Invest Ophthalmol Vis Sci, 44, 5151, 10.1167/iovs.02-1101
Aihara, 2003, Experimental mouse ocular hypertension: establishment of the model, Invest Ophthalmol Vis Sci, 44, 4314, 10.1167/iovs.03-0137
Mabuchi, 2003, Optic nerve damage in experimental mouse ocular hypertension, Invest Ophthalmol Vis Sci, 44, 4321, 10.1167/iovs.03-0138
Morrison, 1997, A rat model of chronic pressure-induced optic nerve damage, Exp Eye Res, 64, 85, 10.1006/exer.1996.0184
Jia, 2000, Patterns of intraocular pressure elevation after aqueous humor outflow obstruction in rats, Invest Ophthalmol Vis Sci, 41, 1380
Aihara, 2003, Aqueous humor dynamics in mice, Invest Ophthalmol Vis Sci, 44, 5168, 10.1167/iovs.03-0504
Aihara, 2003, Twenty-four-hour pattern of mouse intraocular pressure, Exp Eye Res, 77, 681, 10.1016/j.exer.2003.08.011
Quigley, 1989, Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma, Am J Ophthalmol, 107, 453, 10.1016/0002-9394(89)90488-1
Quigley, 1992, An evaluation of optic disc and nerve fiber layer examinations in monitoring progression of early glaucoma damage, Ophthalmology, 99, 19, 10.1016/S0161-6420(92)32018-4
Zangwill, 2000, Evaluating the optic disc and retinal nerve fiber layer in glaucoma II: optical image analysis, Sem Ophthalmol, 15, 206, 10.3109/08820530009037872
Weinreb, 1990, Histopathologic validation of Fourier-ellipsometry measurements of retinal nerve fiber layer thickness, Arch Ophthalmol, 108, 557, 10.1001/archopht.1990.01070060105058
Knighton, 1998, Microtubule contribution to the reflectance of the retinal nerve fiber layer, Invest Ophthalmol Vis Sci, 39, 189
Weinreb, 1999, Evaluating the retinal nerve fiber layer in glaucoma with scanning laser polarimetry, Arch Ophthalmol, 117, 1403, 10.1001/archopht.117.10.1403
Greenfield, 2000, Effect of corneal polarization axis on assessment of retinal nerve fiber layer thickness by scanning laser polarimetry, Am J Ophthalmol, 129, 715, 10.1016/S0002-9394(00)00353-6
Zhou, 2002, Individualized compensation of anterior segment birefringence during scanning laser polarimetry, Invest Ophthalmol Vis Sci, 43, 2221
Weinreb, 2003, Glaucoma detection using scanning laser polarimetry with variable corneal polarization compensation, Arch Ophthalmol, 121, 218, 10.1001/archopht.121.2.218
Bowd, 2003, Association between scanning laser polarimetry measurements using variable corneal polarization compensation and visual field sensitivity in glaucomatous eyes, Arch Ophthalmol, 121, 961, 10.1001/archopht.121.7.961
Weinreb, 1998, Assessment of optic disc topography for diagnosing and monitoring glaucoma, Arch Ophthalmol, 116, 1229, 10.1001/archopht.116.9.1229
Chauhan, 2001, Optic disc and visual field changes in a prospective longitudinal study of patients with glaucoma: comparison of scanning laser tomography with conventional perimetry and optic disc photography, Arch Ophthalmol, 119, 1492, 10.1001/archopht.119.10.1492
Zangwill, 2001, Discriminating between normal and glaucomatous eyes using the Heidelberg Retina Tomograph, GDx Nerve Fiber Analyzer, and Optical Coherence Tomograph, Arch Ophthalmol, 119, 985, 10.1001/archopht.119.7.985
Schuman, 1995, Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography, Arch Ophthalmol, 113, 586, 10.1001/archopht.1995.01100050054031
Zangwill, 2000, A comparison of optical coherence tomography and retinal nerve fiber layer photography for detection of nerve fiber layer damage in glaucoma, Ophthalmology, 107, 1309, 10.1016/S0161-6420(00)00168-8
Guedes, 2003, Optical coherence tomography measurement of macular and nerve fiber layer thickness in normal and glaucomatous human eyes, Ophthalmology, 110, 177, 10.1016/S0161-6420(02)01564-6
Greenfield, 2003, Macular thickness changes in glaucomatous optic neuropathy detected using optical coherence tomography, Arch Ophthalmol, 121, 41, 10.1001/archopht.121.1.41
Sample, 2000, Short-wavelength automated perimetry: its role in the clinic and for understanding ganglion cell function, Prog Retin Eye Res, 19, 369, 10.1016/S1350-9462(00)00001-X
Polo, 2002, Predictive value of short-wavelength automated perimetry: a 3–year follow-up study, Ophthalmology, 109, 761, 10.1016/S0161-6420(01)01014-4
Landers, 2000, A comparison of short wavelength automated perimetry with frequency doubling perimetry for the early detection of visual field loss in ocular hypertension, Clin Experiment Ophthalmol, 28, 248, 10.1046/j.1442-9071.2000.00318.x
Sommer, 1991, Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans: the Baltimore eye survey, Arch Ophthalmol, 109, 1090, 10.1001/archopht.1991.01080080050026
Mitchell, 1996, Prevalence of open-angle glaucoma in Australia: the Blue Mountains eye study, Ophthalmology, 103, 1661, 10.1016/S0161-6420(96)30449-1
Tielsch, 1991, A population-based evaluation of glaucoma screening: the Baltimore eye survey, Am J Epidemiol, 134, 1102, 10.1093/oxfordjournals.aje.a116013
Anon, 1998, The Advanced Glaucoma Intervention Study (AGIS): 3. Baseline characteristics of black and white patients, Ophthalmology, 105, 1137, 10.1016/S0161-6420(98)97012-9
Anon, 1998, The Advanced Glaucoma Intervention Study (AGIS): 4. Comparison of treatment outcomes within race. Seven-year results, Ophthalmology, 105, 1146, 10.1016/S0161-6420(98)97013-0
Kass, 2002, The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma, Arch Ophthalmol, 120, 701, 10.1001/archopht.120.6.701
Gordon, 2002, The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma, Arch Ophthalmol, 120, 714, 10.1001/archopht.120.6.714
Wolfs, 1998, Genetic risk of primary open-angle glaucoma. Population-based familial aggregation study, Arch Ophthalmol, 116, 1640, 10.1001/archopht.116.12.1640
Tielsch, 1994, Family history and risk of primary open angle glaucoma: the Baltimore eye survey, Arch Ophthalmol, 112, 69, 10.1001/archopht.1994.01090130079022
Sheffield, 1993, Genetic linkage of familial open angle glaucoma to chromosome Iq21–q31, Nat Genet, 4, 47, 10.1038/ng0593-47
Stone, 1997, Identification of a gene that causes primary open angle glaucoma, Science, 275, 668, 10.1126/science.275.5300.668
Alward, 1998, Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLC1A), N Engl J Med, 338, 1022, 10.1056/NEJM199804093381503
Fingert, 1999, Analysis of myocilin mutations in 1703 glaucoma patients from five different populations, Hum Mol Genet, 8, 899, 10.1093/hmg/8.5.899
Polansky, 2000, Regulation of TIGR/MYOC gene expression in human trabecular meshwork cells, Eye, 14, 503, 10.1038/eye.2000.137
Clark, 2001, Expression of the glaucoma gene myocilin (MYOC) in the human optic nerve head, FASEB J, 15, 1251, 10.1096/fj.00-0663fje
Parrish, 2002, When does information become medically useful?: the role of genetic testing in glaucoma, Arch Ophthalmol, 120, 1204, 10.1001/archopht.120.9.1204
2000, Preferred Practice Patterns Committee, Glaucoma Panel
Heijl, 2002, Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial, Arch Ophthalmol, 120, 1268, 10.1001/archopht.120.10.1268
Lichter, 2001, Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery, Ophthalmology, 108, 1943, 10.1016/S0161-6420(01)00873-9
2003
Fremont, 2003, Patterns of care for open-angle glaucoma in managed care, Arch Ophthalmol, 121, 777, 10.1001/archopht.121.6.777
1995, The Glaucoma Laser Trial (GLT) and glaucoma laser trial follow-up study: 7. Results. Glaucoma Laser Trial Research Group, Am J Ophthalmol, 120, 718, 10.1016/S0002-9394(14)72725-4
Leske, 2003, Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial, Arch Ophthalmol, 121, 48, 10.1001/archopht.121.1.48
Collaborative Normal-Tension Glaucoma Study Group, 1998, Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures, Am J Ophthalmol, 126, 487, 10.1016/S0002-9394(98)00223-2
Collaborative Normal-Tension Glaucoma Study Group, 1998, The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma, Am J Ophthalmol, 126, 498, 10.1016/S0002-9394(98)00272-4
2001, The Advanced Glaucoma Intervention Study (AGIS): 9. Comparison of glaucoma outcomes in black and white patients within treatment groups, Am J Ophthalmol, 132, 311, 10.1016/S0002-9394(01)01028-5
Gabelt, 1989, Prostaglandin F2 alpha increases uveoscleral outflow in the cynomolgus monkey, Exp Eye Res, 49, 389, 10.1016/0014-4835(89)90049-3
Villumsen, 1989, Prostaglandin F2 alpha-isopropylester eye drops: effect on intraocular pressure in open-angle glaucoma, Br J Ophthalmol, 73, 975, 10.1136/bjo.73.12.975
Weinreb, 1997, Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells, Invest Ophthalmol Vis Sci, 38, 2772
Weinreb, 2002, Effects of prostaglandins on the aqueous humor outflow pathways, Surv Ophthalmol, 47, S53, 10.1016/S0039-6257(02)00306-5
Wistrand, 1997, The incidence and time-course of latanoprost-induced iridial pigmentation as a function of eye color, Surv Ophthalmol, 41, S129, 10.1016/S0039-6257(97)80020-3
Grierson, 2002, Histology and fine structure of the iris and outflow system following latanoprost therapy, Surv Ophthalmol, 47, S176, 10.1016/S0039-6257(02)00304-1
Grierson, 1999, The fine structure of an iridectomy specimen from a patient with latanoprost-induced eye color change, Arch Ophthalmol, 117, 394, 10.1001/archopht.117.3.394
Lindsey, 2001, Induction of tyrosinase gene transcription in human iris organ cultures exposed to latanoprost, Arch Ophthalmol, 119, 853, 10.1001/archopht.119.6.853
Johnstone, 1997, Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost, Am J Ophthalmol, 124, 544, 10.1016/S0002-9394(14)70870-0
Toris, 1999, Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients, Am J Ophthalmol, 128, 8, 10.1016/S0002-9394(99)00076-8
Einarson, 2000, Meta-analysis of the effect of latanoprost and brimonidine on intraocular pressure in the treatment of glaucoma, Clin Ther, 22, 1502, 10.1016/S0149-2918(00)83048-9
Enyedi, 2001, Safety and efficacy of brimonidine in children with glaucoma, J AAPOS, 5, 281, 10.1067/mpa.2001.117571
Diggory, 1996, Medical treatment of glaucoma: a reappraisal of the risks, Br J Ophthalmol, 80, 85, 10.1136/bjo.80.1.85
Schori, 2001, Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma, Proc Nad Acad Sci USA, 98, 3398, 10.1073/pnas.041609498
Kipnis, 2000, T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies, Proc Natl Acad Sci USA, 97, 7446, 10.1073/pnas.97.13.7446
Wise, 1979, Argon laser therapy for open-angle glaucoma: a pilot study, Arch Ophthalmol, 97, 319, 10.1001/archopht.1979.01020010165017
Weinreb, 1995, Laser trabeculoplasty, 1575
Acott, 1989, Trabecular repopulation by anterior trabecular meshwork cells after laser trabeculoplasty, Am J Ophthalmol, 107, 1, 10.1016/0002-9394(89)90805-2
Parshley, 1996, Laser trabeculoplasty induces stromelysin expression by trabecular juxtacanalicular cells, Invest Ophthalmol Vis Sci, 37, 795
Bradley, 2000, Mediation of laser trabeculoplasty-induced matrix metalloproteinase expression by IL-lbeta and TNFalpha, Invest Ophthalmol Vis Sci, 41, 422
Damji, 1999, Selective laser trabeculoplasty v argon laser trabeculoplasty: a prospective randomised clinical trial, Br J Ophthalmol, 83, 718, 10.1136/bjo.83.6.718
Gaasterland, 1992, Initial experience with a new method of laser transscleral cyclophotocoagulation for ciliary ablation in severe glaucoma, Trans Am Ophthalmol Soc, 90, 225
Gupta, 1997, Diode laser transscleral cyclophotocoagulation, J Glaucoma, 6, 426, 10.1097/00061198-199712000-00013
Bloom, 1997, “Cyclodiode”. Trans-scleral diode laser cyclophotocoagulation in the treatment of advanced refractory glaucoma, Ophthalmology, 104, 1508, 10.1016/S0161-6420(97)30109-2
Jay, 1988, Early trabeculectomy versus conventional management in primary open angle glaucoma, Br J Ophthalmol, 72, 881, 10.1136/bjo.72.12.881
Migdal, 1994, Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma, Ophthalmology, 101, 1651, 10.1016/S0161-6420(94)31120-1
Edmunds, 1999, The National Survey of Trabeculectomy. I. Sample and methods, Eye, 13, 524, 10.1038/eye.1999.131
Edmunds, 2002, The National Survey of Trabeculectomy. III. Early and late complications, Eye, 16, 297, 10.1038/sj.eye.6700148
El Sayyad, 2000, Nonpenetrating deep sclerectomy versus trabeculectomy in bilateral primary open-angle glaucoma, Ophthalmology, 107, 1671, 10.1016/S0161-6420(00)00263-3
Jonescu-Cuypers, 2001, Primary viscocanalostomy versus trabeculectomy in white patients with open-angle glaucoma: a randomized clinical trial, Ophthalmology, 108, 254, 10.1016/S0161-6420(00)00514-5
Chiselita, 2001, Non-penetrating deep sclerectomy versus trabeculectomy in primary open-angle glaucoma surgery, Eye, 15, 197, 10.1038/eye.2001.60
O'Brart, 2002, A randomised, prospective study comparing trabeculectomy augmented with antimetabolites with a viscocanalostomy technique for the management of open angle glaucoma uncontrolled by medical therapy, Br J Ophthalmol, 86, 748, 10.1136/bjo.86.7.748
Carassa, 2003, Viscocanalostomy versus trabeculectomy in white adults affected by open-angle glaucoma: a 2-year randomized, controlled trial, Ophthalmology, 110, 882, 10.1016/S0161-6420(03)00081-2
Wilson, 2003, Long-term follow-up of primary glaucoma surgery with Ahmed glaucoma valve implant versus trabeculectomy, Am J Ophthalmol, 136, 464, 10.1016/S0002-9394(03)00239-3
Chen, 1990, Trabeculectomy with simultaneous topical application of mitomycin-C in refractory glaucoma, J Ocul Pharmacol, 6, 175, 10.1089/jop.1990.6.175
Smith, 1992, Results of intraoperative 5-fluorouracil supplementation on trabeculectomy for open-angle glaucoma, Am J Ophthalmol, 114, 737, 10.1016/S0002-9394(14)74053-X
Egbert, 1993, A prospective trial of intraoperative fluorouracil during trabeculectomy in a black population, Am J Ophthalmol, 116, 612, 10.1016/S0002-9394(14)73204-0
Singh, 1997, Trabeculectomy with intraoperative 5-fluorouracil vs mitomycin C, Am J Ophthalmol, 123, 48, 10.1016/S0002-9394(14)70991-2
Yorston, 2001, A randomised trial of the effect of intraoperative 5-FU on the outcome of trabeculectomy in east Africa, Br J Ophthalmol, 85, 1028, 10.1136/bjo.85.9.1028
Weinreb, 1995, Riding the Trojan horse of glaucoma surgery, J Glaucoma, 4, 2, 10.1097/00061198-199502000-00002
Higginbotham, 1996, Bleb-related endophthalmitis after trabeculectomy with mitomycin C, Ophthalmology, 103, 650, 10.1016/S0161-6420(96)30639-8
Greenfield, 1996, Endophthalmitis after filtering surgery with mitomycin, Arch Ophthalmol, 114, 943, 10.1001/archopht.1996.01100140151007
Wells, 2003, Cystic bleb formation and related complications in limbus versus fornix based conjunctival flaps in pediatric and young adult trabeculectomy with mitomycin C, Ophthalmology, 110, 2192, 10.1016/S0161-6420(03)00800-5
Khaw, 2003, Antifibrotic agents in glaucoma surgery